JavaScript is disabled for your browser. Some features of this site may not work without it.
There is no fulltext present in this item.
Title:
Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs
Author(s):
Zuur, M.A.; Pasipanodya, J.G.; Soolingen, D. van; Werf, T.S. van der; Gumbo, T.; Alffenaar, J.W.C.
Publication year:
2018
Source:
Clinical Infectious Diseases, vol. 67, iss. 11, (2018), pp. 1743-1749
Please use this identifier to cite or link to this item :http://hdl.handle.net/2066/199484
Display more details
Subject:
All institutes and research themes of the Radboud University Medical Center Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences